Claims
- 1. A method for treating a viral infection in a warm-blooded animal comprising administering to the warm-blooded animal a therapeutically effective amount of a compound of the following formula:
- 2. A method according to claim 1 wherein said compound is in the form of a pharmaceutically acceptable salt thereof.
- 3. A method according to claim 2 wherein said pharmaceutically acceptable salt is a hydrochloride salt.
- 4. A method according to claim 1 wherein said compound is in the form of a prodrug thereof.
- 5. A method according to claim 1 wherein said compound is in the form of a liposome delivery system.
- 6. A method according to claim 1 wherein said compound is of the following formula A-1:
- 7. A method according to claim 6 wherein R2 is selected from the group consisting of alkyl, haloalkyl, alkenyl, and substituted or unsubstituted benzyl.
- 8. A method according to claim 1 wherein said compound is of the following formula A-2:
- 9. A method according to claim 8 wherein R2 is selected from the group consisting of alkyl, haloalkyl, and substituted or unsubstituted benzyl.
- 10. A method according to claim 1 wherein said compound is micronized and is suitable for administering to said warm-blooded animal by injection.
- 11. A method according to claim 1 wherein said compound is administered in an amount of from 10 mg/kg body weight to 10,000 mg/kg body weight.
- 12. A method according to claim 1 wherein said compound is administered orally, enterically, intravenously, peritoneally, or by injection.
- 13. A method according to claim 1 wherein said compound is administered in a pharmaceutically acceptable carrier.
- 14. A method for treating cancer susceptible to treatment in a warm-blooded animal comprising administering to the warm-blooded animal a therapeutically effective amount of a compound of the following formula:
- 15. A method according to claim 14 wherein said compound is of the following formula A-1:
- 16. A method according to claim 14 wherein said compound is of the following formula A-2:
- 17. A method for treating cancer susceptible to treatment in a warm-blooded animal comprising administering to the warm-blooded animal a therapeutically effective amount of a compound of the following formula:
- 18. A method according to claim 17 wherein said compound is of the following formula A-1:
- 19. A method according to claim 17 wherein said compound is of the following formula A-2:
- 20. A method according to claim 17 wherein said compound is in the form of a pharmaceutically acceptable salt thereof.
Parent Case Info
[0001] The present application is a divisional application of U.S. Ser. No. 09/670,168 filed Sep. 26, 2000.
Divisions (1)
|
Number |
Date |
Country |
Parent |
09670168 |
Sep 2000 |
US |
Child |
10267051 |
Oct 2002 |
US |